All Posts: News Release
-
Collateral Harm: The Impact of Ebola and Related Fears on Facility-Based Child Deliveries
WASHINGTON — The first known household survey examining the collateral harm to pregnancy services in areas affected by the West African Ebola epidemic suggests a significant slide backwards in child and maternal health. The study, conducted in Liberia, points to the deep disruptions caused by the Ebola epidemic — even in parts of the country with relatively limited transmission.
Category: News Release
-
Zika Has Arrived, But is the U.S. Ready?
WASHINGTON –The Florida Department of Health, investigating non-travel related cases of Zika in Miami-Dade and Broward counties, has concluded “that a high likelihood exists that four cases are the result of local transmission.” Despite the advance warning of Zika’s approach, Georgetown experts in infectious disease, public health law, health systems readiness and mosquito research say the United States isn’t ready for a Zika outbreak.
Category: News Release
-
Switch from Observation Only to Active Treatment by Patients with Prostate Cancer Varies by Race and Ethnicity
NEW YORK, NY — Assessment of clinical and nonclinical factors indicates that black men on active surveillance are more likely to pursue active treatment, according to a new study
published in The Journal of Urology.Category: News Release
-
Resveratrol Appears to Restore Blood-Brain Barrier Integrity in Alzheimer’s Disease
TORONTO (July 27, 2016) — Resveratrol, given to Alzheimer’s patients, appears to restore the integrity of the blood-brain barrier, reducing the ability of harmful immune molecules secreted by immune cells to infiltrate from the body into brain tissues, say researchers at Georgetown University Medical Center. The reduction in neuronal inflammation slowed the cognitive decline of patients, […]
Category: News Release
-
More Evidence in Quest to Repurpose Cancer Drugs for Alzheimer’s Disease
TORONTO – An FDA approved drug to treat renal cell carcinoma appears to reduce levels of a toxic brain protein linked to dementia in Alzheimer’s and Parkinson’s diseases when given to animals. This finding is the latest from Georgetown University Medical Center’s Translational Neurotherapeutics Program (TNP) examining tyrosine kinase inhibitors in the treatment of neurodegenerative diseases.
Category: News Release
-
Public Health Benefits of E-cigarette Use Tend to Outweigh the Harms
A modeling study by top tobacco control experts finds that e-cigarettes are likely to provide public health benefits based on “conservative estimates” of the likely uptake of vaping and smoking by adolescents and young adults.
Category: News Release
-
Center for Child and Human Development Honors Renowned Pediatrician
Jack Shonkoff, MD, is the director of Harvard University’s Center on the Developing Child.
Category: News Release
-
NEJM: “TBI’s Long-Term Follow-up — Slow Progress in Science and Recovery”
WASHINGTON – Eleven years ago in the New England Journal of Medicine, medical journalist Susan Okie, MD, first introduced readers to two U.S. Army veterans who suffered traumatic brain injuries in Iraq, and the challenges they faced in the recovery period after returning home. In the July 14 issue of the NEJM, Okie describes her follow-up interviews with the soldiers, and the slow journey to recovery that continues more than a decade later.
Category: News Release
-
Study Tests New Breast Cancer Drug in African American Women
WASHINGTON — The first clinical trial to test a newly approved breast cancer drug specifically in African American patients is now enrolling patients at six institutions in Washington, DC, Maryland, Alabama and New Jersey.
Category: News Release
-
Study: Cancer Drug Restores Brain Dopamine, Reduces Toxic Proteins in Parkinson, Dementia
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (July 11, 2016) — A small proof of concept study provides molecular evidence that an FDA-approved drug for leukemia significantly increased brain dopamine and reduced toxic proteins linked to disease progression in patients with Parkinson’s disease or dementia with Lewy bodies. Dopamine is the brain chemical (neurotransmitter) lost as a result […]
Category: News Release